INR 21.07
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | -1.21 Million INR | -103.06% |
2022 | 39.78 Million INR | 34.1% |
2021 | 29.66 Million INR | 15.28% |
2020 | 25.73 Million INR | 6.45% |
2019 | 24.17 Million INR | 34.14% |
2018 | 18.02 Million INR | 3.65% |
2017 | 17.38 Million INR | 72.65% |
2016 | 10.07 Million INR | 40.57% |
2015 | 7.16 Million INR | 0.0% |
2014 | - INR | 0.0% |
2013 | - INR | 0.0% |
2012 | - INR | -100.0% |
2011 | 14.45 Million INR | -26.93% |
2010 | 19.77 Million INR | -79.19% |
2009 | 95.01 Million INR | -11.56% |
2008 | 107.43 Million INR | 48.64% |
2007 | 72.28 Million INR | 2.68% |
2006 | 70.39 Million INR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q3 | - INR | 0.0% |
2023 Q4 | -1.21 Million INR | 0.0% |
2023 Q2 | - INR | 0.0% |
2023 FY | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q2 | - INR | 0.0% |
2022 FY | 39.78 Million INR | 34.1% |
2022 Q3 | - INR | 0.0% |
2022 Q4 | 39.78 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 FY | 29.66 Million INR | 15.28% |
2021 Q4 | 29.66 Million INR | 0.0% |
2021 Q3 | - INR | 0.0% |
2021 Q2 | - INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 Q4 | 25.73 Million INR | 0.0% |
2020 FY | 25.73 Million INR | 6.45% |
2020 Q2 | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2019 FY | 24.17 Million INR | 34.14% |
2018 Q4 | 18.02 Million INR | 0.0% |
2018 FY | 18.02 Million INR | 3.65% |
2018 Q2 | - INR | 0.0% |
2017 Q4 | 17.38 Million INR | 0.0% |
2017 FY | 17.38 Million INR | 72.65% |
2016 FY | 10.07 Million INR | 40.57% |
2016 Q4 | 10.07 Million INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 Q4 | 7.16 Million INR | 0.0% |
2015 FY | 7.16 Million INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2014 FY | - INR | 0.0% |
2013 Q2 | - INR | 0.0% |
2013 Q4 | - INR | 0.0% |
2013 FY | - INR | 0.0% |
2012 FY | - INR | -100.0% |
2012 Q4 | - INR | 0.0% |
2012 Q2 | 28.4 Million INR | 0.0% |
2011 FY | 14.45 Million INR | -26.93% |
2010 FY | 19.77 Million INR | -79.19% |
2009 FY | 95.01 Million INR | -11.56% |
2008 FY | 107.43 Million INR | 48.64% |
2007 FY | 72.28 Million INR | 2.68% |
2006 FY | 70.39 Million INR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Ajanta Pharma Limited | 235.2 Million INR | 100.518% |
Amrutanjan Health Care Limited | 13.96 Million INR | 108.727% |
Sigachi Industries Limited | 265.79 Million INR | 100.459% |
Bal Pharma Limited | 363.82 Million INR | 100.335% |
Ind-Swift Laboratories Limited | 111.62 Million INR | 101.092% |
Medico Remedies Limited | 8.67 Million INR | 114.057% |
Lasa Supergenerics Limited | - INR | Infinity% |
Venus Remedies Limited | 386.8 Million INR | 100.315% |
Sun Pharma Advanced Research Company Limited | 106.6 Million INR | 101.144% |
Alpa Laboratories Limited | - INR | Infinity% |
Nectar Lifesciences Limited | 1.4 Billion INR | 100.087% |
Shilpa Medicare Limited | 5.6 Billion INR | 100.022% |
Aarti Drugs Limited | 2.75 Billion INR | 100.044% |
Lupin Limited | 1.55 Billion INR | 100.079% |
Aurobindo Pharma Limited | 21.34 Billion INR | 100.006% |
Zydus Lifesciences Limited | 251 Million INR | 100.486% |
Windlas Biotech Limited | 20.18 Million INR | 106.041% |
Suven Life Sciences Limited | - INR | Infinity% |
Eris Lifesciences Limited | 6.54 Billion INR | 100.019% |
Valiant Laboratories Limited | 746.63 Million INR | 100.163% |
J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | 100.516% |
Solara Active Pharma Sciences Limited | 1.05 Billion INR | 100.115% |
Ipca Laboratories Limited | 5.8 Billion INR | 100.021% |
Bliss GVS Pharma Limited | 355.92 Million INR | 100.342% |
Achyut Healthcare Limited | - INR | Infinity% |
Sun Pharmaceutical Industries Limited | 13.3 Million INR | 109.165% |
Bajaj HealthCare Limited | 650.34 Million INR | 100.187% |
RPG Life Sciences Limited | -30.3 Million INR | 95.977% |
Mankind Pharma Limited | 248.67 Million INR | 100.49% |
Laurus Labs Limited | 8.6 Billion INR | 100.014% |
Piramal Pharma Limited | 24.83 Billion INR | 100.005% |
Torrent Pharmaceuticals Limited | 16.04 Billion INR | 100.008% |
Alembic Pharmaceuticals Limited | 628.8 Million INR | 100.194% |
Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 100.08% |
Unichem Laboratories Limited | 382.22 Million INR | 100.319% |
Sequent Scientific Limited | 1.42 Billion INR | 100.085% |
Novartis India Limited | 50.7 Million INR | 102.404% |
Wanbury Limited | 820 Million INR | 100.149% |
Suven Pharmaceuticals Limited | 212.35 Million INR | 100.574% |
Wockhardt Limited | 8.91 Billion INR | 100.014% |
Themis Medicare Limited | 267.74 Million INR | 100.455% |
Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | 101.613% |
Jubilant Pharmova Limited | 31.67 Billion INR | 100.004% |
Glenmark Life Sciences Limited | 147.61 Million INR | 100.826% |
Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 100.02% |
Divi's Laboratories Limited | 20 Million INR | 106.095% |
NATCO Pharma Limited | 53 Million INR | 102.3% |
Gufic Biosciences Limited | 1.53 Billion INR | 100.079% |
IOL Chemicals and Pharmaceuticals Limited | - INR | Infinity% |
Ind-Swift Limited | 10.09 Billion INR | 100.012% |
Procter & Gamble Health Limited | 68.8 Million INR | 101.772% |
FDC Limited | 2.46 Million INR | 149.432% |
Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 100.066% |
Granules India Limited | 689.71 Million INR | 100.177% |
Medicamen Biotech Limited | 12.55 Million INR | 109.709% |
Alkem Laboratories Limited | 400 Million INR | 100.305% |
AstraZeneca Pharma India Limited | 27.83 Million INR | 104.379% |
Biofil Chemicals and Pharmaceuticals Limited | - INR | Infinity% |
Brooks Laboratories Limited | 3.56 Million INR | 134.194% |
Megasoft Limited | 1.35 Billion INR | 100.09% |
ZIM Laboratories Limited | 356 Million INR | 100.342% |
Strides Pharma Science Limited | 6.71 Billion INR | 100.018% |
Neuland Laboratories Limited | 449.2 Million INR | 100.271% |
Morepen Laboratories Limited | 33.64 Million INR | 103.624% |
Hikal Limited | 4.22 Billion INR | 100.029% |
Indoco Remedies Limited | 3.51 Billion INR | 100.035% |
Aarti Pharmalabs Limited | 400 Thousand INR | 404.75% |
Kilitch Drugs (India) Limited | - INR | Infinity% |
Mangalam Drugs & Organics Limited | 133.54 Million INR | 100.913% |
Hester Biosciences Limited | 1.81 Billion INR | 100.067% |